Wednesday, May 8, 2019

Targeted Oligonucleotide Delivery



Here is a seemingly nicely written article about the application of targeted oligo delivery conjugation therapies.

With a deal and a debut, targeted oligo delivery gets a boost from ADCs

We have actually reported on both of these before, but its always nice when a real journalist does some journalism.  (This blog has never, and will never claim to be real journalism)

https://www.adcdaily.com/2019/04/lilly-taps-aviditys-antibody.html

No comments:

Post a Comment